The respiratory infection sector represents a significant application area for fluoroquinolone antibiotics, leveraging their broad spectrum, excellent lung tissue penetration, and convenient oral bioavailability across community-acquired and nosocomial respiratory infections. In community-acquired pneumonia, respiratory fluoroquinolones including levofloxacin and moxifloxacin provide effective...